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1 Introduction 
 
The genome of every cell in an organism contains the information which is necessary to 
give rise to all specialized cell types with their different cellular functions. There are 
several hundred distinct cell types in a human body, which all contribute equally to the 
complexity of an organism. Therefore, for the successful development of a multicellular 
organism, cell identity is not simply defined by the genetic information provided by the 
DNA double helix, but also from transcriptional control of expression. Epigenetic 
regulation, involving chromatin remodelling, histone modifications and DNA 
methylation, was identified to play an important role in cell differentiation and therefore 
in the identity of the cell. Chromatin composition changes during development as 
shown by changing patterns of epigenetic modifications and the dynamics of chromatin 
proteins (Meshorer, et al., 2006) (Buszczak and Spradling, 2006). How chromatin 
modifications are regulated during development and epigenetic patterns are established 
is presently a focus of research. Understanding of the underlying mechanism of 
heterochromatin formation and stable gene silencing will help to achieve insights in the 
mechanism of induced pluripotency which is a current interest in regenerative medicine.  
  
1.1 Dosage compensation 
 
One important example of epigenetic regulation is dosage compensation, which happens 
in the early embryogenesis. In mammals, the unequal genetic imbalance of XY males 
and XX females has to be compensated. The mechanism of dosage compensation 
accomplishes that there is only one active X chromosome (Xa) in every cell of an 
organism (Lyon, 1961). In female somatic cells this is achieved by silencing all but one 
X chromosomes by the establishment of a heterochromatic structure and the inactive X 
chromosome (Xi) was first described as barr body (Barr and Bertram, 1949).  
 
 
 
 
 
Introduction 
2 
1.2 Dynamic activity state of the inactive X chromosome  
The inactive X chromosome undergoes several rounds of in- and reactivation during 
development (Fig. 1).  
During the first cleavages in early female mouse embryonic development, the paternally 
inherited X chromosome becomes inactive (Okamoto, et al., 2005) (Okamoto, et al., 
2004) and remains inactive in extraembryonic tissues like the primitive endoderm and 
trophectoderm (Heard and Disteche, 2006). At the blastocyst stage at embryonic day 3.5 
(E3.5), the X chromosome of cells of the inner cell mass (ICM) is reactivated. These 
cells give rise to the embryo proper later in development (Mak, et al., 2004). Before 
gastrulation at E5.5 random X inactivation is accomplished which leads to a mosaic 
pattern of female somatic cells either with the maternal or the paternal X chromosome 
inactivated (Heard and Disteche, 2006).  
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Figure 1 X chromosome inactivation in mouse embryonic development  
adopted from review Wutz, A. (Wutz, 2011) 
 
Fertilization of the oocyte by a spermatocyte leads to a diploid zygote consisting of a 
maternal and a paternal chromosome set. After the first cleavages blastocyst stage is 
achieved at E3.5 consisting of the trophectoderm and the ICM. The paternal X 
chromosome is inactivated during the first cleavages and is maintained in cells of the 
extraembryonic tissue. The inactive X chromosome is reactivated in cells of the ICM. In 
the female developing epiblast two active X chromosomes are present between E3.5 and 
E5.5 and before gastrulation either the maternal or the paternal X chromosome gets 
inactive by random X inactivation which is stable inherited in female somatic cells. 
Another round of reactivation takes place during migration of female primordial germ 
cells. 
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The inactive X chromosome is stable in somatic cells (Heard and Disteche, 2006) but 
gets reactivated in primordial germ cells and during oogenesis in female cells (Chuva de 
Sousa Lopes, et al., 2008).  Pluripotent mouse embryonic stem cells (ESCs), which are 
derived from female blastocysts (Penny, et al., 1996) have two active X chromosomes. 
During differentiation X inactivation is established and therefore can be used as an in 
vitro model to study the mechanism of chromosome-wide silencing. 
 
1.3 The X inactivation centre 
 
Silencing of one of the two X chromosomes is regulated by the expression of the non-
coding X inactivation specific transcript (Xist) from the X inactivation centre (Xic) 
(Brockdorff, et al., 1991) (Fig. 2). The Xic is an essential gene locus for X inactivation 
and plays an important role in the counting mechanism that ensures that all but one X 
chromosomes are silenced per cell (Monkhorst, et al., 2008). The minimal gene region 
for Xic in mice has been defined and lies between the T16H and the HD3 breakpoint 
spanning 10-20 Mb (Eicher, et al., 1972) (Rastan, 1983). Xist RNA expression is 
controlled by various regulators located at the Xic. 
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Figure 2 The X inactivation centre (Xic)   adopted from (Augui, et al., 2011) 
 
The 10-20 Mb long locus defined as X inactivation centre and surrounding elements are 
shown: Nap1l2 (nucleosome assemby protein 1-like 2), Cdx4 (caudal X linked gene), 
Chic1 (cysteine rich hydrophobic1), Tsx (testis specific X linked), Jpx (expressed 
neighbour of Xist), Ftx (five prime to Xist), Cnbp2 (cellular nucleic acid binding protein 
2), Xpct (X-linked PEST-containing transporter) and Rnf12 (Ring finger protein 12). 
Xist RNA locus, its antisense gene Tsix and the regulators Xite (X inactivation 
intergenic transcription element) and DXPas34 are indicated in the enlarged image.  
 
 
 
How these regulatory elements act in X inactivation still remains to be determined. 
Previous investigations propose that the Jpx locus, which produces a non-coding RNA 
(ncRNA) triggers female specific Xist activation (Tian, et al., 2010). Another ncRNA 
transcribed from the Ftx locus is believed to control the expression of Xist, Tsix and Jpx 
in male cells (Chureau, et al., 2011). Chromosomal pairing around the Xic regions, 
transgenic protein factors such as RNF12 and long and short transcripts have been 
implicated in regulating X inactivation (Augui, et al., 2007) (Bacher, et al., 2006). In 
addition YY1 and CTCF might structure chromatin at the Xic (Jeon and Lee, 2011). It is 
currently thought that all these regulatory elements convene at controlling the activation 
of Xist. Once Xist is upregulated it initiates inactivation of the X chromosome. 
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1.4   Chromosome-wide silencing triggered by Xist RNA 
 
Several regulators of Xist RNA have been identified which include transcription factors 
such as Nanog and Oct4 (Guo, et al., 2009) (Navarro, et al., 2010) or the non-coding 
Tsix RNA which is transcribed antisense to Xist (Lee, et al., 1999). The 17-19 kb long 
Xist RNA is transcribed specifically from the inactive X chromosome and accumulates 
within the Xi chromosome territory in the interphase nucleus (Clemson, et al., 1996). 
This is accompanied by the exclusion of parts of the transcription machinery like RNA 
polymerase II (Pol II) and splicing factors (Okamoto, et al., 2004) (Chaumeil, et al., 
2006) known as “Pol II hole”. The initiation and following events of chromosome-wide 
silencing have been studied well in mouse ESCs with transgenes on the X chromosome 
as well as on autosomes (Wutz and Jaenisch, 2000). While Xist RNA expression is 
essential in the initiation process of chromosome-wide silencing, other mechanisms are 
responsible for the maintainance and inheritance of the inactive chromosome and Xist 
RNA can not initiate silencing in differentiated cells (Wutz and Jaenisch, 2000). The 
stable gene silencing on the Xi in somatic cells is maintained by epigenetic mechanisms 
including DNA methylation (Sado, et al., 2004) and histone H4 hypoacetylation, which 
is a hallmark of the Xi (Keohane, et al., 1996). After accumulation of Xist RNA over the 
chromosome, Polycomb group (PcG) complexes are recruited which play an important 
role as histone modifying proteins (Schwartz and Pirrotta, 2008). PcG proteins are 
known to contribute in development, dosage compensation and Hox gene regulation and 
two PcG complexes accomplish the establishment of chromatin modifications for gene 
regulation in mammals (Pietersen and van Lohuizen, 2008). The Polycomb-repressive 
complex 2 (PRC2) causes trimethylation of histone H3 lysine 27 (H3K27m3) (Czermin, 
et al., 2002) and PRC1 mediates mono-ubiquitination of histone H2A lysine 119 
(H2AK119ub1) (de Napoles, et al., 2004). PRC2 consists of Eed, Suz12 and Ezh2 
proteins and a mutation in Eed causes the loss of H3K27m3 (Boyer, et al., 2006). PRC1 
contains the proteins Ring1A and Ring1B. The loss of Ring1B causes derepression of 
developmental control genes but its function in X inactivation seems to be compensated 
by other complexes (Leeb and Wutz, 2007). 
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1.5  Xist function during development 
 
The ability of expressed Xist RNA to induce chromosome-wide silencing depends on a 
cellular context and timepoint in development. Up to embryonic day 9.5, Xist RNA 
remains functional in the initiation of gene silencing, whereas Xist in differentiated cells 
as mouse embryonic fibroblasts (MEFs) loses silencing function but still localizes to the 
chromosome (Wutz and Jaenisch, 2000). Furthermore, studies showed that expression 
of Xist RNA after embryonic day 12.5 is compatible with development but the 
haematopoietic system is affected leading to perinatal lethality (Savarese, et al., 2006). 
These investigations showed that precursor cells in the haematopoietic system possess 
the cellular context for Xist RNA initiation of gene silencing (Agrelo, et al., 2009).  
 
 
1.6 Xist RNA composition 
 
Established ESC systems led the way to investigate X inactivation in an in vitro model 
and introduction of transgenes carrying deletions allowed to investigate Xist RNA 
domains important for localization, modifications and gene repression (Fig. 3). A 
deletion study showed that the 17-19 kb long mouse Xist RNA contains several 
sequence domains that mediate localization but none of them is essential and can be 
compensated (Wutz, et al., 2002). The nuclear protein Saf-A/hnRNPU co-localizes with 
Xist RNA in the nucleus and is thought to contribute to chromosome attachment 
(Kukalev, et al., 2009). Previous investigations identified the protein YY1 contributing 
to Xist RNA loading onto the inactive X chromosome. YY1 is a bivalent protein which 
binds the AAnATGGCG motif on DNA and Xist RNA via Repeat C and is essential for 
Xist RNA localisation (Jeon and Lee, 2011). 
Chromatin modifying complexes as PRC1 and PRC2 are recruited and H3K27m3, 
H2AK119ub1 and H4K20m1 are established at the Xist RNA localization site. 
Furthermore, the histone variant macroH2A and the chromosomal protein Ash2L are 
recruited to contribute to the formation of a repressive compartment (Beletskii, et al., 
2001) (Pullirsch, et al., 2010). Whereas macroH2A and Ash2L require Xist for their 
recruitment to the Xi, H4 hypoacetylation is stable when Xist expression is lost due to a 
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somatic deletion (Csankovszki, et al., 1999). H4 hypoacetylation on the Xi is 
established at the transition to maintenance of XCI (Pullirsch, et al., 2010). How H4 
hypoacetylation is maintained on the Xi independent of Xist is unclear.  
 
 
 
 
 
 
Figure 3 Xist RNA sequence function adopted from (Arthold, et al., 2011) 
 
17-19 kb long Xist RNA with proteins and chromatin modifications necessary for  
X inactivation are indicated. The 500 nucleotide long repeat A sequence at the 5´region 
is essential for gene repression. Proteins such as Ezh2, Suz12, Asf/Sf2 and Satb1 are 
associated with this domain. More yet unknown proteins with function in the cellular 
context of gene silencing are indicated with a question mark. In somatic cells the 
maintenance of gene silencing is accomplished by DNA methylation of CpG islands by 
the proteins SmcHD1 and Dnmt1. A nuclear protein associated with chromosomal 
localization is Saf-A (also known as hnRNPU), chromatin modifying complexes as 
PRC1 and PRC2 and chromosomal proteins as macroH2A and Ash2L are recruited to 
the Xi. Histone H4 hypoacetylation is established independent of Xist RNA 
accumulation.  
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1.7  Repeat A and stable gene silencing  
 
Deletion studies revealed a repeated sequence at the 5´end of Xist RNA which is 
essential for the initiation of gene repression and is called repeat A sequence (Wutz, et 
al., 2002). Xist RNA carrying this 500 bp deletion still localizes to the chromosome and 
all chromatin modifications are established, but no gene silencing can be observed 
(Chaumeil, et al., 2006). Further investigations showed that male ESCs carrying the Xist 
RNA lacking repeat A on their X chromosome are able to differentiate in vitro with just 
little effect on gene expression and the term of Xiag chromosome (inactive X 
chromosome with active genes) was established (Pullirsch, et al., 2010). Proteins 
interacting with repeat A sequence include Ezh2 and Suz12, which are part of the PRC2 
complex (Cao, et al., 2002) and the splicing factor Asf/Sf2 (Royce-Tolland, et al.). The 
homeobox domain protein Satb1 plays an important role in the cellular context of gene 
silencing in T cell differentiation (Agrelo, et al., 2009) and proteins which might act 
similar in function still have to be investigated. To accomplish stable gene silencing in 
differentiated somatic cells, DNA methylation of CpG rich promoters are established by 
SmcHD1 and Dnmt1 (Blewitt, et al., 2008; Sado, et al., 2000; Vasques, et al., 2005). 
Studies of the effect of Dnmt1 null mutations in mice on X inactivation showed that 
imprinted genes in the extraembryonic tissue are uneffected whilst random X 
inactivation in cells of the embryo proper was unstable and imprinted genes got 
reactivated due to hypomethylation (Sado, et al., 2000). These investigations suggest 
that methylation is required to maintain stable X inactivation in cells of the embryonic 
lineages but imprinting in cells of the extraembryonic lineages is compatible with 
demethylation. Furthermore, studies on somatic cells with a conditional mutant Xist 
allele show that Xist RNA expression, DNA methylation and histone H4 
hypoacetylation act synergistically to maintain stable gene silencing in somatic cells 
(Csankovszki, et al., 2001).  
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1.8 Model of a repressive compartment 
 
To explain the discovery of a chromosome possessing all heterochromatin marks known 
from the inactive X chromosome without significant gene silencing, a model of a 
repressive compartment has been suggested, whereof genes and non-genic regions 
might be regulated separately (Chaumeil, et al., 2006) (Fig. 4). This model aims to 
explain how genes escape repression by coexistent formation of heterochromatin in 
cells expressing Xist RNA without repeat A. It is believed that actively transcribed 
genes locate on the periphery of the chromosome territory where they are accessible to 
components of the transcription machinery. The repressive compartment is established 
on the Xi chromosomal territory where Xist RNA accumulates. Chromatin modifying 
complexes as PRC1 and PRC2 are recruited to this area, components of the 
transcription machinery are excluded and late replication is established. It is believed 
that in the case of Xist RNA without repeat A genes might not associate with the 
repressive environment and escape transcriptional silencing. 
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Figure 4 Repressive compartment  adopted from (Arthold, et al., 2011)  
 
Before inactivation, the X chromosome (A) shows active transcribed genes on the 
periphery of the chromosomal compartment. After Xist RNA expression it localizes 
over the territory of the inactive X chromosome (B, indicated in red). The repressive 
compartment is established by recruitment of chromatin modification complexes, 
exclusion of factors of the transcription machinery and late replication. For gene 
silencing a developmental context and repeat A sequence of Xist RNA are required. It is 
thought that proteins as Satb1 might be necessary to link chromatin loops to the 
repressive compartment and induce repression (C). The maintenance of silenced genes 
is accomplished by histone H4 hypoacetylation, chromatin modifications established by 
PcG complexes and recruitment of macroH2A, SmcHD1 and Dnmt1 (D).  
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1.9  Inducible Xist RNA expression system 
 
For studying Xist RNA expression, its role in initiation of chromosome-wide silencing 
and the establishment of chromatin modifications, an inducible heterologous expression 
system in mouse ESC is used (Fig. 5). The transactivator protein nls-rtTA (indicated in 
blue) is expressed from the ubiquitously active Rosa26 (R26) locus. By the addition of 
doxycycline (dox, indicated in green) the transactivator can bind to the promoter 
sequence in trans on chromosome 11 and induces Xist RNA, without repeat A (ColXist, 
indicated in red) expression.  
 
 
 
Figure 5 Inducible Xist RNA expression system adopted from (Wutz, 2007) 
 
The used inducible Xist RNA expression system is shown schematically. The in trans 
transcribed transactivator nls-rtTA (blue) is expressed from the R26 locus and can bind 
to the promoter on chromosome 11 with addition of doxycycline (green). Transgene 
ColXist RNA (red) expression is induced.  
 
 
This system provides for investigations on Xist RNA function in different timepoints in 
development and transgene expression on X chromosome as well as on various 
autosomes. Previous studies to obtain insight in the complex mechanism of X 
inactivation and chromosome-wide silencing were performed using this established 
inducible system, e.g. on investigating the developmental window in which Xist RNA 
can induce silencing (Wutz and Jaenisch, 2000), deletion studies to investigate sequence 
functions of Xist (Wutz, et al., 2002), studies on chromosomal protein recruitment 
(Pullirsch, et al.) or the role of Polycomb group in X inactivation (Leeb and Wutz, 
2007) (Leeb, et al.).  
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1.10 Aims of this study 
 
1.10.1 Consequences of ColXist RNA expression in early mouse 
development 
 
Previous investigations showed that the expression of an Xist RNA lacking repeat A 
from the X chromosome in male embryonic stem cells is compatible with differentiation 
in vitro (Pullirsch, et al., 2010), which suggests no significant silencing function of the 
transgenic Xist RNA. This study aims to investigate if the expression of Xist RNA 
without repeat A, expressed from chromosome 11, is also compatible with mouse 
embryonic development. The phenotypic consequences of homozygous and 
heterozygous ColXist RNA expression from embryonic day 4.5 will be investigated and 
the consequences of chromatin modifications and gene silencing will be studied. 
 
1.10.2 Effect of ColXist RNA expression in tissue stem cell niches 
 
The second aim of this study is to investigate the effect of ColXist RNA expression in 
developing mice from embryonic day 12.5 to obtain insight on the effect in the 
haematopoietic system. Previous studies showed that Xist RNA induction after E12.5 is 
compatible with normal development until birth, but leads to death shortly after birth, 
due to severe problems in haematopoiesis (Savarese, et al., 2006). To investigate the 
effect of transgenic ColXist RNA expression from chromosome 11, heterozygous 
induction will be accomplished over a time period of four weeks and phenotypic 
consequences will be studied. 
 
1.10.3 Genome-wide gene expression profiling 
 
The third aim of this study is to identify to which extent homozygous expression of 
ColXist RNA lacking repeat A leads to misregulation of genes. Therefore, an 
established in vitro ESC system is used to compare expression differences of genes in 
cells with or without ColXist RNA induction in differentiation using Affymetrix 
analysis. Furthermore, it will be investigated if identified misregulated genes are 
Introduction 
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expressed in ES cells and induced upon lineage formation in differentiation and if these 
genes are Polycomb target genes or targets of other epigenetic systems. 
 
These investigations will provide insights into the function of epigenetic modifications 
in development. The observation of a chromosome which carries all chromatin 
modifications known from the Xi (Xiag) with only little effect on gene expression was 
surprising (Pullirsch, et al., 2010) and with this study we hope to get insights into the 
underlying molecular mechanisms. Furthermore, we address the question how the non-
coding Xist RNA lacking repeat A prevents gene upregulation in an autosomal context 
that is independent of its gene repression function. 
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2 Materials and Methods 
 
2.1    Cultivation of eukaryotic cells 
 
Cell culture work was performed under sterile, class II safety conditions. Used solutions 
were steril-filtered (0,2% gelatine was autoclaved) and all consumables desinfected with 
70% ethanol before use. Cells were cultured in a CO2 incubator (Sanyo, 37°C, 5% 
CO2).  
 
2.1.1 Consumable materials 
 
Aspirator pipettes   FALCON
TM
 
Cell culture plates 6-well plate, 48-well plate, 96-well plate, IWAKI 
microplate, polystyrene 
Cell culture flasks   T25, T75, IWAKI, polystyrene  
Cell culture dishes   FALCON
TM
, polystyrene 
 
 
Pipettes    5 ml, 10 ml, 25 ml, COSTAR
®
 Stripette 
Tubes     15 ml, 50 ml, FALCON
TM
 
 
 
2.1.2 Solutions 
 
Accutase    provided by tissue culture core facility 
Bovine serum, heat inactivated  GIBCO, Ref# 26170-035 
BSA fraction V   GIBCO, Ref# 15260-037 
β-Mercaptoethanol   Aldrich, Cat# M6250 
Concanavalin A   Calbiochem, Cat# 234567 
DMEM PAA, high glucose 4,5g/l, without L-glutamine,  
Cat# E15-009 
DMEM/Ham´s F-12 PAA, without L-glutamine, Cat# E15-012 
DMSO,Dimethyl Sulfoxide Sigma, D8418 
Doxycycline  1mg/ml (1000x) stock 
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Foetal Bovine Serum  PAA, A15-080 
Fibronectin Millipore, hu plasma fibronectin, FC010 
Gelatine 0,2% in H2O, autoclaved 
HEPES buffer 1M PAA, Cat# S11-001 
L-glutamine  GIBCO, 200mM, Ref# 25030-024 
M2 medium SIGMA-ALDRICH, M7167 
M16 medium SIGMA-ALDRICH, M7292 
N2B27  Ndiff
®
, neural differentiation medium, Stem Cells 
Inc., Cat# SCS-SF-NB-02 
Non essential amino acids (NEAA) GIBCO, 100x, Ref# 11140-035 
PBS with Ca+Mg PAA, Dulbecco´s 1x phosphate buffered saline,  
Cat# H15-001 
PBS without Ca+Mg  PAA, Dulbecco´s 1x phosphate buffered saline,  
Cat# H15-002  
PenStrep GIBCO, 5000 units penicillin, 5000 µg 
streptomycin, Cat# 15070-063  
RPMI-1640 GIBCO, Cat# 31870     
Retinoic acid 10mg/ml stock 
Sodium pyruvate  GIBCO, 100mM, Ref# 11360-039 
Trypsin/0,02% EDTA used 0,25% in PBS, GIBCO  
 
 
 
2.1.3 Established cell lines 
 
X
3
 cells, mouse fibroblasts, female 
 
X³ cells are derived from a mammary cell line with a stable karyotype and two inactive  
X chromosomes (Wutz and Jaenisch, 2000). 
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2.1.4 Primary cell lines 
 
MEFs derived from transgene bearing COLtetOP Xist ΔSX/+R26TA [H] mice, E9.5 to 
E14.5 
 
For the isolation of MEFs, pregnant mice were sacrificed at E9.5 to E14.5, uteri 
dissected and embryos kept in PBS. The embryos were transferred to a sterile tissue 
culture hood, tissue was disintegrated with a syringe and cells cultured in MEFs 
medium either with or without doxycycline at 37°C/5% CO2. 
 
  
2.1.4.1 Thymus and spleen cells 
 
Splenocyte culture medium 
 
250ml RPMI 
 + 10% heat inactivated serum 
 + 2,5ml HEPES buffer 
 + 2,5ml PenStrep 
 + 0,7µl β-Mercaptoethanol 
 add  40µg/ml concanavalin A shortly before use 
 
For the isolation of thymus and spleen cells, 19 and 20 days old mice, heterozygous for 
inducible ColXist RNA, with doxycycline induction for approximately 4 weeks, were 
sacrificed, thymus and spleen were dissected and kept in PBS. In a sterile cell culture 
hood, thymus and spleen tissues were disintegrated with a cell strainer (BD FALCON, 
70µm nylon) and cultured in splenocyte medium, with or without doxycycline, at 
37°C/5% CO2. The mitogen concanavalin A was used for stimulation of proliferation in 
vitro and IF analysis was performed after two days in culture. 
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2.1.4.2 ESC derivation 
 
ESC medium (serum and LIF) 
 
200ml DMEM 
 +15% foetal bovine serum 
 + 2ml PenStrep 
 + 2ml pyruvate 
 + 2ml L-glutamine 
 + 2ml NEAA 
 + 200µl murine LIF 
 
stock of inhibitors 
 10µl PDO3 
 30µl Chiron  
 in 1ml M16 medium 
 
For the derivation and establishment of ESC lines homozygous for ColXist, E3.5 
pregnant mice were sacrificed and uteri were dissected. Under a brightfield microscope 
the uteri were flushed with M2 medium and blastocysts were collected. The blastocysts 
were transferred to an in vitro fertilization dish with M16 medium, 1ml M16 containing 
10µl of inhibitor-stock for expansion of the inner cell mass, and incubated over night at 
37°C/5% CO2. The next day the zona pellucida was removed by incubating the 
blastocysts quickly in acid tyrodes. After washing in M2 medium, blastocysts were 
transferred to a 96-well plate in 2i
+
 medium and were incubated for 2 days. For the first 
passage a 48-well plate was coated for one hour with gelatine, to accomplish proper 
attachment. Cells were trypsinized with 25µl trypsin/EDTA and trypsinization stopped 
after 7 minutes by adding ESC medium (with serum and LIF). By pipetting up and 
down for approximately 10 times a single cell suspension was prepared and cells 
transferred to a 48-well plate in 2i
+
 medium. Backfreezes were made with passage 4. 
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2.1.5 Freezing cells 
 
MEFs, X³ and ESCs were mixed 1:1 with 20% DMSO/80% foetal bovine serum in 
freezing vials (10% DMSO final concentration) and kept at -80°C. 
 
2.1.6 Thawing cells 
 
Cells were thawed in a 37°C waterbath, culture medium was added and cells spun 
down. The cell pellet was resuspended in culture medium, transferred to a tissue culture 
flask and further cultured according to cell type.  
 
2.1.7 Cultivation of Mouse Embryonic Fibroblasts (MEFs) and X3 cells 
  
MEF medium 
 
500ml DMEM 
 + 10% foetal bovin serum 
 + 5ml PenStrep 
 + 5ml L-glutamine 
 + 5ml Sodium pyruvate  
+ 5ml Non essential amino acids (NEAA) 
+ 4µl β-Mercaptoethanol 
  
MEFs and X³ cells were split after they reached about 70% confluence. Therefore, 
medium was discarded and attached cells washed thoroughly two times with 1xPBS. A 
few drops of trypsin/EDTA were added and cells incubated at 37°C for 5 minutes. 
Detached cells were resuspended in 3ml medium and passaged in the correct ratio (1:3 
or 1:6) to a new tissue culture flask or plate. 
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2.1.8 Cultivation of embryonic stem cells in 2i medium 
 
Preparation of 2i
+
 culture medium 
 
200ml N2B27 (either the commercial or the self-made N2B27) 
 + 10ml BSA fraction V   
 + 400µl LIF 
 + 60µl Chiron  
 + 20µl PD03 
 final concentrations of inhibitors are 3µM Chiron and 1µM PD03 
 
N2B27 medium 
500mL Neurobasal medium   GIBCO, Ref# 21103-049 
500mL DMEM/Ham´s F-12  PAA, without L-glutamine, Cat# E15-012 
10mL B-27 supplement (50x) GIBCO, Ref# 17504-044 
10mL Glutamine 
5mL N2 supplement   Batch 0410-015  
8µL  β-meEtOH  
washing buffer 
 
500ml DMEM Ham´s F-12 
 + 3ml BSA fraction V 
 
 
Mouse embryonic stem cells were cultured and maintained under 2i conditions on 
gelatine-coated tissue culture plates. Therefore, all used flasks, plates and slides were 
coated with 0,2% gelatine for at least 30 minutes. For passing, culture medium was 
discarded and cells were washed 2 times with PBS. For detaching, a few drops of 
accutase were added and cells incubated for 5min at 37°C. To accomplish a single cell 
suspension, tissue culture flasks and plates were hit against the hand several times and 
cells were resuspended thoroughly in 3ml of washing buffer. After centrifugation for 5 
minutes at 800rpm the washing buffer was discarded, the pellet resuspended in 1ml of 
2i medium and cells were split according to their growth density (1:6, 1:10). ESCs were 
passaged every other day and cultivated at 37°C/5% CO2. 
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2.1.9 ESC differentiation with retinoic acid 
 
Differentiation medium 
 
500ml DMEM 
 + 10% foetal bovin serum 
 + 5ml PenStrep 
 + 5ml L-glutamine 
 + 5ml Sodium pyruvate  
+ 5ml Non essential amino acids (NEAA) 
+ 4µl β-Mercaptoethanol 
+ 2µl retinoic acid 
 
For the differentiation of ESCs with retinoic acid, ESCs were detached and pellets 
resuspended as described above. ESCs were split in ratios depending on their 
confluence (between 1:20 to 1:40) on gelatine-coated plates in differentiation medium 
and cultured for 4 to 6 days at 37°C/5% CO2. Medium was changed after 2 days of 
culture. Depending on the experimental approach, differentiated cells were either grown 
on ROBOZ slides for IF stainings or FISH for another night or cells were count and 
RNA isolated for further gene expression analysis. 
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2.2   Cytological methods 
 
2.2.1 RNA FISH  
 
Solutions and buffer 
 
1xPBS 
Cytosceletal buffer  
 
100 mM NaCl 
300 mM sucrose 
3 mM MgCl2  
10 mM PIPES pH 6,8 
(store at 4°C) 
 
Cytosceletal buffer + detergent 
 
100 mM NaCl 
300 mM sucrose 
3 mM MgCl2 
10 mM PIPES ph 6,8 
0,5% Triton X-100 
(store at 4°C) 
(detergent and concentration vary with cell type) 
 
4% paraformaldehyde/1xPBS 
 
Ethanol (abs, 95%, 80%, 70%) 
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20x SSC 
175,3 g NaCl 
88,2 g sodium citrate in 800ml of H2O 
adjust pH to 7.0 with a few (!) drops of HCl (32%) 
adjust volume to 1l 
 
Formamide 
Tween-20 
Triton X-100 
DAPI    4´,6´-diamidino-2-phenyl-indole, dihydrochloride, invitrogen 
0,5M EDTA pH 8 adjust with NaOH pellets ~20-30g 
3M NaOAc pH 5,2  adjust with acetic acid (glacial) 
1M PIPES pH 6,8  adjust with NaOH pellets, ~2g per 50ml 
 
1x TE buffer  
10mM Tris Cl pH 7,5 
1 mM EDTA pH 8 
 
Vectashield
®
 Mounting Medium, Vector Laboratories Cat# H-1000 
 
Xist probe preparation 
 
- label 1µl of tetOP-Xist plasmid by random priming using the random primer 
labeling kit (Agilent Technologies Prime-lt (R) II) 
- in an eppendorf tube with a screw cap add 
o 22µl MilliQ (autoclaved) 
o 1µl plasmid 
o 10µl random primers 
- incubate 5min at 95°C in heatblock 
- put 5min on ice 
- add 
o 10µl 5x dCTP  
o 0,5µl Cy3-dCTP 
o 1µl Klenow pol. 
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- Mix thouroughly, wrap in aluminium foil 
- incubate at 37°C in incubator o/n 
 
- the next day remove unlabelled nucleotides by using a spun column kit (clontech 
laboratories L-Art-Nr: 636069, Chroma spin TE, 50 col) 
- shake column to loose column bed and take care not to have any buffer on the 
lid 
- remove closure of the column, put column into an eppendorf tube with screw 
cap and put it into a 15ml tube 
- spin to remove TE buffer, 800rpm, 5min 
use 2ml H2O in 15ml tube as balance 
- remove column, put it into a new eppendorf tube and 15ml tube 
 
- add 1µl of 0,5M EDTA pH8 to probe (amplified the day before) 
- pipett on column 
- add 20µl TE buffer 
- spin 1000rpm, 10min 
- discard column 
- labelled probe in TE buffer in the eppendorf tube in 15ml tube 
- pipett out into a new eppendorf tube 
- add: 
o 20µl yeast tRNA [20ng/ml] 
o 20µl salmon sperm DNA [10mg/ml] invitrogen 
o 20µl mouse Cot-1 DNA [1µ/µl] 
o 1/10 of volume of NaOAc pH 5,2 (~20µl) 
o 21/2 of volume of EtOH abs (~500µl) 
- vortex! 
- Store at -20°C  
 
- spin 30 min at 13000rpm, 4°C (balance with ~700µl) 
- discard supernatant 
- add 1ml of 70% EtOH 
- briefly vortex 
- spin 5 min at 13000rpm, 4°C 
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- add 1ml of abs EtOH 
- spin 1 min at 13000rpm, 4°C 
- take off SN 
- spin briefly and remove the remaining SN 
- air dry pellet by opening the tube, wrap it in alumiunium foil and put it in a 
drawer ~30 min 
- resuspend pellet by adding 80µl of hybridisation buffer (HYBRISOL VII, MP) 
add ~20 µl onto the pellet and break it into smaller pieces, pipet up and down 
with the 80µl until the whole pellet is dissolved! (it takes a few minutes) 
- shake it 10 min on a shaker (wrapped in aluminium foil!) 
- add 240µl of hybridisation buffer 
- incubate 10 min at 74°C 
- incubate 30 min at 37°C 
- store at -20°C 
 
Fixing cells 
 
- Grow cells over night on ROBOZ slides (HTC(R), 10 wells 7mm) at 37°C / 5% 
CO2 
- Wash 2x mit PBS in coplin jar 
- Incubate 2 min with cytoskeletal buffer + detergent 
- Wash with PBS 
- Fix 10 min with 4% paraformaldehyde (PFA) 
- Wash with 70% EtOH 
- At this step there is the possibility to store the fixed cells in 70% EtOH at 4°C 
- Or continue with dehydration 
 
Dehydration 
 
- remove from 70% EtOH 
- place in 80% EtOH for 2 min 
- place in 95% EtOH for 2 min 
- place in 100% EtOH for 2 min 
- air dry, possibility to store slides in 70% EtOH 
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- add 3 µl of Xist probe/well and cover with coverslip 
- place in a humid 37°C chamber o/n (use a large petry dish, layer some Whatman 
paper soaked in 50% formamide/2x SSC in the bottom) 
 
 
Washing 
 
- prewarm all solutions to 39°C in water bath 
- remove the cover slip very carefully by dipping the slide into the washing 
solution before the washing steps 
- wash slides in 2x SSC/50% formamide (special waste!) 3x 5min in coplin jar 
(~50ml) 
at 39°C water bath with agitation 
- wash in 2x SSC 3x 5 min, 39°C with agitation 
- wash in 1x SSC/1µl DAPI 10 min, 39°C with agitation 
- add a drop of mounting media to a large cover slip, place slide on it and fix 
cover slip with nail polish 
- image acquisition with Leica CTR6000 fluorescence microscope  and LAS AF 
software 
- store slides at 4°C in the dark 
 
 
2.2.2 Immunofluorescence analysis 
 
Immunofluorescence stainings were performed either on interphase nuclei or condensed 
methapase chromosome spreads. Three different staining protocols were established and 
used, depending if single stainings or co-stainings were performed. For 
immunofluorescence analysis, combined with a subsequent Xist RNA FISH, a seperate 
protocol was used, aiming RNase free conditions. Primary and secondary antibodies 
were used in different combinations and image acquistion was performed with Leica 
CTR6000 fluorescence microscope  and LAS AF software. 
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solutions and buffer 
 
KCM buffer 
 10mM  TrisHCl pH 8 
 120mM KCl 
 20mM  NaCl 
 0,5mM  EDTA 
 
RBS solution 
 10mM  TrisHCl pH 7,5 
 10mM  NaCl 
 5mM  MgCl2 
 
10% Triton X-100 stock 
10% Tween-20 stock  
 
Preparation for interphase staining 
 
For immunofluorescence analysis on interphase nuclei, cells were grown on gelatin-
coated ROBOZ slides over night at 37°C / 5% CO2.  
 
Preparation of metaphase chromosome spreads 
 
For immunofluorescence analysis on condensed methaphase chromosome spreads, cells 
were prepared after the following protocol: 
 
metaphase arrest 
 
 add 1:100 demecolcine to ~70% confluent cells in flask (in case of 9ml in T25 
flask add 90µl of demecolcine) 
 mix well and incubate for 3-4 hours at 37°C / 5% CO2 
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collecting cells 
 
 briefly tap flask to loose the slightly adherent cells and collect the medium in a 
15ml tube 
 wash the attached cells 2x with 5ml PBS and trypsinize with 4 drops of trypsin 
for 5min at 37°C / 5% CO2 
 resuspend the cells with the medium collected earlier and spin cells down, 5min, 
800rpm 
 discard the medium and resuspend cells in 2ml RBS  
 incubate 15min at 37°C 
 
cytospin cells 
 
 clean  poly-lysine coated glass slides (SIGMA-ALDRICH, poly-prepTM slides,  
Ref# P0425-72EA) with 70% EtOH and dry them 
 fix slides in special cytospin aparature as followed: 
o first add the slide (make sure to put the right side up!) 
o wet special filters (glass slide size, with holes) with PBS and put on 
slides 
o finally add the plastic applicator 
 add 100-200µl of cell suspension per hole in the applicator  
 make sure to close the rotor properly 
 centrifuge in Cytospin 4 centrifuge (Shandon) for 10 min with 1200 rpm  
   
 
2.2.3 Histone H3 trimethyl-lysine 27 (H3K27m3) IF-staining 
 
This protocol was used for single H3K27m3 stainings. 
 
 extract cells on prepared slides in KCM/0,1% Tween-20/0,1% Triton X-100 for 
10min at RT in coplin jar 
 fix in 4% PFA/PBS for 10min at RT 
 wash in KCM/0,1% Tween-20 
 block in KCM/0,1% Tween-20/5% BSA for 30min at RT 
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incubation with primary antibody 
 
 dilute primary antibody  
1:500 in KCM/0,1% Tween-20/5% BSA 
 add 100µl antibody dilution per slide and cover with small coverslip or with a 
small piece of parafilm 
 incubate either for 2 hours at RT or over night at 4°C in a humid chamber (with 
PBS) 
 
washing  
 
 remove coverslips/parafilm carefully by dipping them into washing buffer 
 wash 3x 5min with KCM/0,1% Tween-20 at RT in coplin jar 
   
incubation with secondary antibody 
 
 dilute secondary antibody 1:500 in KCM/0,1% Tween-20/5% BSA 
 add 100µl of antibody dilution per slide and cover with small coverslip or with a 
small piece of parafilm 
 incubate 40min at RT in the dark 
 
washing, mounting and imaging 
 
 wash 3x 5min in KCM/0,1% Tween-20 
 counterstain in 50ml PBS/5µl DAPI (1:10000), 10min at RT 
 wash with PBS 
 add mouning media (Vectashield®), cover with a big cover slip, seal with 
nailpolish and store at 4°C in the dark 
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2.2.4 H4 acetylation IF-staining 
 
This protocol was used for single H4 acetylation stainings and differs from the other 
protocols by the late fixation step. 
 
 block prepared slides in KCM/0,1% Triton X-100/5% BSA for 30min at RT in 
coplin jar  
 
incubation with primary antibody 
 
 dilute primary antibody 1:500 in KCM/0,1% Triton X-100/5% BSA 
 add 100µl antibody dilution per slide and cover with small coverslip or with a 
small piece of parafilm 
 incubate either for 2 hours at RT or over night at 4°C in a humid chamber (with 
PBS) 
 
washing  
 
 remove coverslips/parafilm carefully by dipping them into washing buffer 
 wash 3x 5min with KCM/0,1% Triton X-100 at RT in coplin jar 
   
incubation with secondary antibody 
 
 dilute secondary antibody 1:500 in KCM/0,1% Triton X-100/5% BSA 
 add 100µl of antibody dilution per slide and cover with small coverslip or with a 
small piece of parafilm 
 incubate 40min at RT in the dark 
 
washing, fixing and imaging 
 
 wash 3x 5min in KCM/0,1% Triton X-100 
 fix slides in 4% PFA, 10min at RT in coplin jar 
 counterstain in 50ml PBS/5µl DAPI (1:10000), 10min at RT 
 wash with PBS 
 add mouning media and store at 4°C in the dark 
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2.2.5 General Immunofluorescence protocol for co-stainings 
 
This protocol was used for all co-stainings. For the staining of ubiquitinylated histone 
H2A an additional extraction step before fixation is necessary. 
 
- wash prepared slides in 1xPBS 
- only for ubiquitinylated histone H2A: extract 2 min with PBS/0,5% Triton X-
100 
-fix in 4% PFA/PBS for 10 min  
- wash 2x5 min with 1xPBS 
- permeabilize 3 min in PBS/0,5% Triton X-100 
 -wash slides in 1xPBS 
 -wash slides 2x5 min in PBS/0.1% Triton X-100 
 -block for 30 min in PBS/0,1% Triton X-100/5% BSA 
 dilute primary antibody 1:500 in PBS/0,1% Triton X-100/5% BSA 
 add 100µl antibody dilution per slide and cover with small coverslip or with a 
small piece of parafilm 
 incubate either for 2 hours at RT or over night at 4°C in a humid chamber (with 
PBS) 
 
washing  
 
 remove coverslips/parafilm carefully by dipping them into washing buffer 
 wash 3x 5min with PBS/0,1% Triton X-100 at RT in coplin jar 
   
incubation with secondary antibody 
 
 dilute secondary antibody 1:500 in PBS/0,1% Triton X-100/5% BSA 
 add 100µl of antibody dilution per slide and cover with small coverslip or with a 
small piece of parafilm 
 incubate 40min at RT in the dark 
 
washing, fixing and imaging 
 
 wash 3x 5min in PBS/0,1% Triton X-100 
 counterstain in 50ml PBS/5µl DAPI (1:10000), 10min at RT 
 wash with PBS 
 add mouning media and store at 4°C in the dark 
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2.2.6 Indirect immunofluorescence staining with subsequent Xist RNA FISH 
 
For IF analysis with subsequent FISH, immunostaining was performed as described 
above. To reduce RNA degradation, Rnase Inhibitor (Rnasin
®
, Promega N251B, 
40u/µl) was added to the blocking solution and to the primary and secondary antibody 
dilutions (20u/100µl) and general Rnase free work was aimed. After incubation with the 
secondary antibody, slides were washed 2 times with PBS/0,1% Tween-20, fixed in 4% 
PFA/PBS for 10 min and extracted for 5 min in cytoskeletal buffer/0,1% Triton-X100. 
For subsequent Xist RNA FISH analysis the FISH protocol was followed. 
 
2.2.7 Antibodies 
  
2.2.7.1 Primary Antibodies 
 
Anti-hyperacetylated Histone H4 (Penta) host: rabbit 
Millipore, polyclonal Antibody 
 Cat# 06-946 
Use 1:500 for IF 
 
Anti-Histone H3 trimethyl-lysine 27  host: rabbit 
Active motif, polyclonal Antibody  
Cat# 39155 
Use 1:500 for IF 
 
host: mouse      
      Active motif, monoclonal Antibody 
 Cat# 39536 
Use 1:500 for IF 
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Anti-Histone H4 monomethyl-lysine 20 host: rabbit 
      Active motif, polyclonal Antibody 
Cat# 39175 
Use 1:500 for IF 
 
      host: mouse 
      Active motif, monoclonal Antibody  
Cat# 39727 
Use 1:500 for IF 
 
Anti-Histone macro H2A1   host: rabbit 
      Active motif, polyclonal Antibody  
Cat# 39593 
Use 1:500 for IF 
 
Anti-ubiquityl-Histone H2A, clone E6C5 host: mouse 
      Millipore, monoclonal Antibody  
Cat# 05-678 
Use 1:500 for IF 
 
Anti-Ring1B     host: mouse  
Use 1:500 for IF 
 
Anti-ASH2     host: rabbit 
      Bethyl Laboratories Inc., Cat# A300-107A 
Use 1:500 for IF 
 
Anti-Oct-3/4     host: goat 
      Santa Cruz Biotechnology Inc., (N-19):  
sc-8628  
Use 1:300 for IF 
      host: mouse 
      Santa Cruz Biotechnology Inc. 
Use 1:200 for IF 
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Anti-Nanog     host: rabbit  
Use 1:200 for IF 
 
Anti-Klf4     host: goat 
Use 1:20 for IF 
 
2.2.7.2 Secondary Antibodies 
 
Goat-anti-rabbit    Invitrogen, Alexa Fluor 555
®
, red, A21429 
 
Goat-anti-mouse  Invitrogen, Alexa Fluor 488
®
, green, 
A11029
  
 
Donkey-anti-rabbit  Invitrogen, Alexa Fluor 488
®
, green, 
A21206 
 
Donkey-anti-mouse    Invitrogen, Alexa Fluor 546
®
, red, A10036 
 
Donkey-anti-goat  Invitrogen, Alexa Fluor 647
®
, far red, 
A21447 
 
All secondary antibodies were used 1:500 for IF. 
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2.3    Molecular methods 
 
2.3.1 Isolation of genomic DNA from ESC 
 
Solutions and buffer 
 
Ear buffer 
1% SDS 
20mM EDTA 
50mM NaCl 
50mM Tris pH7.5 
 
Proteinase K  20mg/ml stock solution 
5M NaCl 
Isopropanol 
70% EtOH 
 
 cells from a confluent 6-well plate were accutazed, pellets resuspended in 500µl  
ear buffer/400µg/ml proteinase K and over night incubated at 55°C 
 
DNA precipitation 
 
 add 200µl of 5M NaCl 
 vortex well 
 spin 15 min at 13000 rpm, 4°C 
 transfer supernatant to a new eppendorf tube and add 700µl Isopropanol (1:1) 
 vortex well 
 spin 30 min at 13000 rpm, 4°C 
 discard supernatant 
 add 500µl 70% Ethanol 
 vortex  
 spin 10 min at 13000 rpm, 4°C 
 remove Ethanol 
 airdry and resuspend DNA in 50µl TE buffer by shaking for 1 hour at 65°C 
 keep at -20°C 
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2.3.2 Sex determination by PCR 
 
Solutions and buffer 
 
PCR Master Mix, 2X from Promega (Cat# M7502) 
50 units/ml of Taq DNA polymerase supplied in a proprietary  
reaction buffer (pH 8.5), 400μM 
dATP, 400μM dGTP, 400μM dCTP, 400μM dTTP, 3mM MgCl2  
 
Primer 
 Zfy, Tsix 
 
6x loading dye 
100bp DNA ladder (BioLabs) 
 
Approach 
 
template 1µl 
2xMM 12,5µl 
forward primer 0,4µl 
reverse primer 0,4µl 
H2O 10,7µl 
 25µl 
   
 
PCR program 
 
1 94°C 1 min 
2 94°C 30 sec 
3 56°C 30 sec 
4 72°C 1 min 
5 4°C ∞ 
 
steps 2-4  35 cycles 
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Preparation of 1% agarose gel 
 
1,5g Agarose were dissolved in 150ml 1xTAE buffer and 3µl Ethidiumbromid were 
added. 
 
RNA isolation for Affymetrix genome-wide expression profiling  
 
For RNA isolation the RNeasy Kit from Qiagen (Cat# 74106) was used. Three 
independently derived ESC cell lines were differentiated with or without doxycycline, 
respectively, in 10 cm cell culture dishes for 5 days. Cells were trypsinized, 350µl of 
RLT buffer was added and cells disrupted and homogenized by vortexing for 1 minute. 
1 volume of 70% ethanol was added, the whole sample transferred to an RNeasy spin 
column and centrifuged at 10000rpm for 15s. The flow-through was discarded, 350µl of 
RW1 added and centrifuged at 10000rpm for 15s. For additional DNase digestion, 78µl 
of RNase-free DNase mix was added directly on the spin column membrane and 
incubated for 15min at room temperature. The flow-through was discarded, 350µl of 
RW1 added and centrifuged at 10000rpm for 15s. 500µl of RPE buffer were added, 
centrifuged at 10000rpm for 2min and columns were transferred to new collection 
tubes. Finally the RNA was eluted by adding 30µl of RNase-free water and 
centrifugation at 10000rpm for 1min. RNA concentration and purity was measured with 
Nanodrop and RNA samples kept at -80°C. 1µg of each RNA sample was load on a 
0,7% agarose gel under RNase-free conditions to check the grade of RNA degradation. 
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3 Results 
 
3.1  Autosomal Xist mediated silencing 
 
For investigating the effect of Xist RNA without repeat A expression from   
chromosome 11 in an in vivo model, mice carrying the inducible transgene were 
generated. First, the transgene homing cassette was integrated into the 3´end of Col1a1 
locus on chromosome 11 by homologous recombination in ES cells. This cassette 
carries a doxycycline inducible operator (tetOP) (Fig. 6). The Xist cDNA construct 
PGK-Xist-PA was integrated into the targeting vector Col1a1-tetOP[EV]pSF1-PGKHy 
by Cre recombination, thereby restoring a PGK-neo-pA gene which confirs G418 
resistance (Fig. 7).  
 
 
 
 
Figure 6 A transgene homing site in the Col1a1 locus on chromosome 11 
 
The targeting vector Col1a1-tetOP[EV]pSF1-PGKHy on the Col1a1 locus on 
chromosome 11 is shown. It contains the dox inducible promoter (tetOP), a loxP site 
(black triangle) and an antibiotic resistance marker to accomplish efficient selection of 
cells with integrated transgene. 
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Enlargement
 
Figure 7      Cre mediated insertion on an Xist cDNA transgene into the homing site 
 
Single copy integration of the PGK-Xist-PA via Cre recombination into the homing site 
of Col1a1 locus on chromosome 11 is indicated. LoxP sites are indicated with black 
triangles. Enlargement shows the restoration of G418 resistance necessary for 
identification of transgenic cells. The dox incucible promoter (tetOP) is indicated as a 
hatched box which ensures incucible expression of the transgene Xist RNA. 
 
 
With the transgenic ESCs carrying inducible Xist RNA lacking repeat A on 
chromosome 11 (ColXist RNA) efficient germline transmission could be obtained and 
by breeding to mice carrying the transactivator, R26/N-nlsrtTA [BL/6,H], an inducible 
in vivo system was established. 
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3.2 In vivo expression of ColXist RNA from chromosome 11 in early 
development 
 
Previous investigations showed that the expression of a mutant Xist RNA lacking repeat 
A can trigger the recruitment of heterochromatin marks known from the inactive           
X chromosome independent of gene silencing in an in vitro ESC system (Pullirsch, et 
al., 2010) (Wutz, et al., 2002). Male cells carrying the the mutant Xist RNA transgene 
on their X chromosome are capable to differentiate in culture devoid of significant cell 
death (Pullirsch, et al., 2010). 
 We aimed to investigate if the establishment of facultative heterochromatin but not 
gene silencing is compatible with early embryonic mouse development. Therefore 
crosses with different genotypes were generated (table 1). The effect of Xist induction 
on embryogenesis and survival was studied. Cytological characterization was performed 
to characterize Xist expression and chromatin modifications.  
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Cross 
Nr. of 
mice 
Induced 
ColXist 
expression 
Dissection 
Embryonic 
lethality 
Nr. of dead 
embryos 
dead/all 
Homozygous 
 
ColXist/ColXist 
1 E4.5 E13.5 + 6/6 
 1 E5.5 E12.5 + 8/8 
Maternal 
transmission 
 
ColXist/+ 
2 E6.5 E13.5 + 14/14 
 1 E2.5 E9.5 + 6/6 
 2 E4.5 E11.5 + 12/12 
Paternal 
transmission 
 
+/ColXist 
1 E6.5 E13.5 + 8/8 
No transgene 
induction 
Control 
 
ColXist/+ 
2 - E14.5 - 0/12 
No transgene 
Control 
 
+/+ 
2 E6.5 E13.5 - 0/10 
 
 
Table 1 Overview of crosses 
 
Summary of the different crosses, their genotypes and parental origin of the transgene. 
The number of pregnant mice is given and embryonic days (ED) of Xist induction and 
timepoint of dissection is indicated. Number of normal developed embryos is cited and 
embryonic lethality indicated with +/-. 
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3.2.1 Homozygous cross results in embryonic lethality 
 
To investigate the effect of ColXist expression from chromosome 11 in vivo in early 
mouse development, two timed matings of transgenic mice (ColtetOPXist∆) with mice 
carrying the transactivator (R26TA) were set up. We first aimed for mice, homozygous 
for the ColXist transgene, ColXist/ColXist. Expression of the mutant Xist RNA was 
induced from embryonic day E4.5 and E5.5, respectively, by adding a 
doxycycline/sucrose mix to the drinking water of pregnant females. At E13.5 and 
E12.5, pregnant mice were sacrificed and uteri were dissected. Surprisingly, six out of 
six and eight out of eight embryos were resorbed and showed no signs of proper 
development, although the placenta seemed normally developed. This severe effect on 
early mouse development was completely unexpected as no significant gene silencing 
was expected by the expression of the mutant Xist RNA lacking repeat A. It was not 
possible to isolate any MEFs for further experiments from these embryos.   
 
3.2.2 Heterozygous maternal transgene transmission with genotype 
ColXist/+   
 
To investigate if heterozygous ColXist expression has a severe effect on early 
development as well, five timed matings for ColXist/+ genotype, maternal transgene 
transmission, were set up and ColXist expression was induced with doxycycline from 
E6.5, E2.5 and E4.5, respectively. Mice were sacrificed and uteri dissected at E13.5, 
E9.5 and E11.5. Again, all the embryos (14/14, 6/6 and 12/12) showed the unexpected 
strong phenotype and embryos were not developed properly. However, MEFs were 
isolated from four resorbed embryos (induced from E2.5 and dissected at E9.5), from 
which two cultures could be maintained over a short period in vitro.  
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3.2.3 Transgenic ColXist RNA expression and accumulation in          
E9.5 MEFs, shown by Xist RNA FISH analysis 
 
To verify inducible transgene ColXist RNA expression from chromosome 11, Xist RNA 
FISH analysis was performed in interphase nuclei of MEFs after short term culture with 
doxycycline. The hybridisation with an Xist RNA probe revealed one signal per nucleus 
in ~80% of cells in the first cell line, which showed induced ColXist RNA expression 
from chromosome 11 of male MEFs (Fig. 8 A,B). Short term cultivation of the MEF 
cell line without doxycycline did not reveal any Xist RNA signal in the nuclei, which 
suggests accurate heterozygous ColXist RNA expression from the autosome. 
Hybridization in the second cell line, cultured without doxycycline in vitro revealed one 
signal per interphase nucleus, which shows the endogenous expressed Xist RNA of the 
inactive X chromosome in female cells (Fig. 8 G,H). Short term cultivation with 
doxycycline revealed two Xist RNA signals per nucleus, which verified efficient 
ColXist RNA expression and accumulation on chromosome 11 (Fig. 8 I, J). 
 
3.2.4 Establishment of facultative heterochromatin modifications in 
E9.5 MEFs 
 
To investigate to what extent chromatin modifications are established on the autosome 
expressing the mutant ColXist RNA in comparison to the inactive X chromosome, 
immunofluorescence stainings for detecting histone modifications were accomplished. 
Therefore, histone H4 hypoacetylation and enriched histone H3 lysine 27 tri-
methylation, known as inactive X chromosome markers, were chosen. Previous 
investigations indicate that H3K27m3 is an early mark of X inactivation and an 
enriched signal can be detected in about 70% of cells after 48 hours of Xist induction, 
independent of silencing (Kohlmaier, et al., 2004) (Plath, et al., 2003). The 
chromosomal analysis was mainly performed on condensed metaphase chromosome 
spreads in order to assess the distribution of histone modifications accurately. Male 
E9.5 MEFs cells reveal one chromosome with enriched H3K27m3 signal after short 
term cultivation in vitro with doxycycline (Fig. 8E). A co-staining with H4 acetylation 
antibody was performed to assess the characteristics of H3K27m3 enrichment and      
H4 hypoacetylation in the same metaphase spread. The chromosome with enhanced 
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H3K27m3 signal still shows H4 acetylation, although reduced near the centromeric 
region (Fig. 8D). The observation of a partial hypoacetylation of chromosome 11 is 
different to the chromosome-wide hypoacetylation of H4 reported on the inactive X 
chromosome (Keohane, et al., 1996). Female E9.5 MEFs reveal two enriched 
H3K27m3 signals after short term cultivation in vitro with doxycyline (Fig. 8M). The 
combined histone H4 acetylation staining indicate the inactive X chromosome with 
chromosome-wide H4 hypoacetylation and one partially hypoacetylated chromosome 
11 (Fig. 8L).  
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Figure 8  Xist RNA FISH and IF co-stainings in heterozygous male and female 
E9.5 MEFs 
 
Xist RNA FISH in interphase nuclei of derived E9.5 male MEFs show one signal in 
around 80% of cells, shown in red is cy3 labelled Xist RNA probe (A, B). DNA is 
stained with DAPI, shown in blue. Derived E9.5 female MEFs reveal the endogenous 
Xist RNA accumulation without culture with doxycycline (G, H) and two signals per 
interphase nuclei after induced transgene expression (I, J). IF co-stainings with 
antibodies against H4 hyperacetylation and H3K27m3 were performed on condensed 
metaphase chromosome spreads. After transgene induction one chromosome shows 
enrichment of H3K27m3 shown in green (E) and no significant H4 hypoacetylation can 
be observed (D) in male cells. Female cells show two enriched H3K27m3 marks (M) 
after transgene induction and one hypoacetylated chromosome (L) which shows the 
inactive X chromosome.  
 
 
 
 
 
 
 
 
Results 
47 
3.2.5 Transgenic ColXist RNA expression in E11.5 MEFs,          
genotype ColXist/+ 
 
Two MEF cell lines were isolated from E11.5 resorbed embryos with transgenic ColXist 
RNA induction from E4.5, maternal transmission. Xist RNA FISH was performed with 
cells after short term in vitro cultivation with doxycycline to assess accurate transgene 
expression and revealed one Xist RNA signal in about 80% of male cells (Fig. 9, 
A,B,G,H). Short term cultivation of these cells without doxycycline revealed no Xist 
RNA signal in interphase nuclei, which indicates two male MEF cell lines with 
functional transgene expression from chromosome 11. 
 
 
 
Figure 9 Xist RNA FISH and IF co-stainings in heterozygous male E11.5 
MEFs 
 
Xist RNA FISH indicates one induced ColXist RNA on chromosome 11 in male MEFs, 
shown in red (A, B, G, H). Antibodies against H3K27m3 and H4 hyperacetylation show 
one condensed metaphase chromosome with enriched H3K27m3, indicated in green (E, 
K). H4 acetylation staining in the same metaphase spread shows no significant H4 
hypoacetylation on chromosome 11 (D, J). 
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3.2.6 Establishment of facultative heterochromatin modifications in 
E11.5 MEFs  
 
For investigating the establishment of heterochromatin modifications, histone H4 
hyperacetylation and H3K27m3 co-stainings were performed on condensed metaphase 
chromosomes. Like in E9.5 MEF cells reported above, an enrichment of H3K27m3 and 
partial hypoacetylation could be observed on chromosome 11 after short term in vitro 
cultivation with doxycycline (Fig. 9 C-F, I-L). 
 
In conclusion, maternal transmission of the transgenic ColXist RNA, expressed 
heterozygously from chromosome 11 early in development, shows a surprisingly severe 
phenotype and no proper embryonic development can be accomplished. Cytological 
investigations on isolated MEFs show accurate ColXist expression from the autosome 
and establishment of facultative heterochromatin modifications. Enhanced H3K27m3 
signals can be observed in around 80% of cells in both, male and female MEFs after 
short term cultivation with doxycycline, whereas histone H4 hypoacetylation does not 
appear chromosome-wide on the autosome.  
 
3.2.7 Heterozygous paternal transgene transmission with genotype 
+/ColXist 
 
To rule out any maternal effect of the transgene, one timed mating for +/ColXist 
genotype, paternal transmission, was set up and ColXist expression was induced with 
doxycycline from E6.5. Mice were sacrificed and uteri dissected at E13.5. Eight out of 
eight embryos showed the same severe phenotype and therefore parental transmission of 
the transgene does not influence the phenotype of X inactivation. No MEFs were 
isolated from these embryos for further cytological experiments. 
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3.2.8 Effect of the integrated transgene without in vivo induction, 
genotype ColXist/+ 
 
For investigating a possible effect of the integrated transgene, two timed matings for 
ColXist/+ genotype were set up without ColXist induction in the in vivo model and uteri 
were dissected at E14.5. Twelve out of twelve proper devoloped embryos could be 
obtained suggesting no effect of the integrated transgene in early mouse development. 
Twelve MEF cell lines were taken in culture to investigate accurate ColXist RNA 
expression and establishment of chromatin modifications after late induction in vitro. 
MEFs were either cultivated with or without doxycycline and sex determination by Xist 
RNA FISH analysis revealed seven female and five male cell lines whereas female cells 
show two signals (endogenous and transgenic Xist) and male cells just the transgenic 
ColXist RNA signal after doxycycline induction (Fig. 10 C,D and K,L).  
For analyzing the colocalization of Xist and ColXist RNA, respectively, with the 
enriched heterochromatin mark H3K27m3, immunofluorescence stainings with 
subsequent RNA FISH analysis were performed. Focal signals of H3K27m3 in 
interphase nuclei can be shown which colocalize with either endogenous Xist RNA or 
transgenic ColXist RNA signal upon induction with doxycycline (Fig. 10 C-F). One 
H3K27m3 enrichment shows a weak signal which is explained by the subsequent FISH 
analysis treatment followed by general weaker immunofluorescence signals. Further 
cytological investigations showed that H3K27m3 still can be established on the 
autosome in around 80% of MEFs when ColXist expression is induced in vitro. The 
inactive X chromosome in female cells shows chromosome-wide H4 hypoacetylation in 
comparison to the partial deacetylation of chromosome 11 (Fig. 10 G-J, M-P), which is 
consistant with results from ColXist induction in vivo early in development. 
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Figure 10  Xist RNA FISH and IF co-stainings in heterozygous male and 
female E14.5 MEFs 
 
Xist RNA FISH analysis shows the endogenous Xist RNA in each interphase nucleus in 
female E14.5 MEFs without transgene induction (A, B). The co-localisation of 
endogenous Xist RNA and transgenic ColXist RNA, respectively, with H3K27m3 
enrichment is shown (C-F). Male MEFs reveal one Xist RNA signal per interphase 
nucleus after induction (K, L). Immunofluorescence analysis on metaphase spreads 
show two chromosomes with enriched H3K27m3 signal in female MEFs (H), 
chromosome-wide hypoacetylation of the Xi and no significant decrease in acetylation 
on the autosome (I). In induced male MEFs chromosome 11 shows enrichement of 
H3K27m3 (N) and no obvious hypoacetylation (O).   
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3.2.9 Effect of doxycycline/sucrose mix to the drinking water,             
genotype +/+ 
 
To investigate a possible toxic effect of the inducer molecule doxycycline on mouse 
development, two timed matings of mice without the transgene with mice carrying the 
transactivator were set up. Doxycycline was added to the drinking water of pregnant 
mice starting at E6.5 and uteri were dissected at E13.5. Ten out of ten proper developed 
embryos could be obtained which suggests no toxic effect of doxycycline treatment. 
 
3.2.10 ColXist expression from chromosome 11 mediates H3K27m3 but 
no noticeable decrease in histone H4 acetylation 
 
Our investigations show that expression of the mutant Xist RNA from chromosome 11 
mediates enrichment of H3K27m3 mark on chromosome 11 in around 80% of cells 
after induction in early development as well as in late induction in in vitro cultured 
MEFs (Fig. 11C). The enlarged images of the inactive X chromosome (Fig. 11A) and 
chromosome 11 (Fig. 11B) show the comparison of the chromosome-wide H4 
hypoacetylation on the inactive X chromosome and partial deacetylation of 
chromosome 11, especially close the centromeric region. 
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Figure 11 Immunofluorescence co-stainings and percentage of H3K27m3 after 
early in vivo and late in vitro induction of ColXist RNA expression 
 
IF staining for H3K27m3 (green) and H4 hyperacetylation (red) reveal the differences 
of chromosome-wide H4 hypoacetylation of the inactive X chromosome in female 
control cells (E, F) and the hardly noticeable deacetylation of chromosome 11 after 
ColXist expression (K,L). The percentage of H3K27m3 on chromosome 11 after 
induction of ColXist expression in vivo in early development (grey bars) and in vitro 
induction with doxycycline in culture (blue bars) amounts to around 80%. Grey bars 
represent four indipendently derived MEF cell lines with ColXist/+ genotype and 
ColXist induction at E4.5 and 6.5, respectively and three different metaphase spreads 
per cell line are included. Blue bars represent four independently derived MEF cell lines 
with ColXist/+ genotype and ColXist induction in culture with three different metaphase 
spreads per cell line included. 
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3.3 In vivo expression of ColXist from chromosome 11 in late 
development 
 
To investigate if expression of ColXist RNA at a late timepoint in development has an 
effect on cell differentiation in stem cell niches, we induced ColXist expression 
heterozygously from chromosome 11 from E11.5 over a time period of four weeks. A 
possible effect of the transgenic Xist RNA expression in the haematopoietic system 
could be investigated after all different cell types got renewed in this time period and 
would most likely originate in a severe phenotype. The examination of twenty days old 
mice showed no obvious phenotype in appearance or behaviour, suggesting that ColXist 
RNA expression has no severe effect in late embryogenesis and the turnover in the 
haematopoietic system. For characterising the establishment of chromatin 
modifications, spleen and thymus were dissected and cells taken in culture. Cell 
proliferation was stimulated for 48 hours by adding the T-cell mitogen concanavalin A 
in a concentration of 40µg/ml to the culture medium. To assess the distribution of 
chromatin modifications accurately, immunofluorescence stainings were performed on 
condensed metaphase chromosome spreads. Analysis show enrichment of H3K27m3 
mark on one chromosome 11 in around 80-90% of male cells (Fig. 12B) , which 
suggests establishment of facultative heterochromatin marks independent of silencing 
function by repeat A. The co-immunofluorescence staining with H4 acetylation 
antibody reveals one not significantly deacetylated chromosome 11, which confirms 
results from ColXist expression in early development (Fig. 12A).  
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Figure 12  Immunofluorescence co-staining of isolated spleen cells and 
percentage of  H3K27m3 enrichment 
 
IF co-staining with H3K27m3 antibody (A, green) and H4 hyperacetylation  antibody 
(A, red) reveals enrichment of H3K27m3 on one chromosome 11. The enlarged image 
shows no significant hypoacetylation of the autosome. The percentage of H3K27m3, 
measured in 2 different isolated male spleen cell lines, amounts to around 80%.  
 
 
3.4 ColXist expression shows no obvious phenotype in mouse brain 
development 
 
To investigate whether ColXist expression from a late timepoint in development has any 
effect on the developing mouse brain, mice were treated with doxycycline from E11.5 
over a period of four weeks. Eight weeks after birth brains were dissected, weighed and 
compared to brains of control mice which carried no transgene but had undergone the 
same treatment with doxycycline. Results show no significant differences in weight 
between the controls and the transgene induced brains. Female brains with induced 
ColXist expression show slightly higher weight then the controls but not in a significant 
range and could be caused by biological differences or dissection method (Fig. 13A). 
For investigating if the transgene expression has any effect on the development of the 
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cortical layers, sagittal cryosections were prepared and histologically compared to the 
controls without transgene expression. Comparison between the control and the 
experimental sections was carried out by diverse images of sectional views and 
therefore inaccurate. However, no severe developmental failures of important structures 
as the cerebellum, the hippocampus or the cortical layers could be observed (Fig.13B). 
 
 
 
Figure 13 Influence of ColXist expression from E11.5 on mouse brain 
development 
 
Comparison of mouse brain development without ColXist induction (A, male indicated 
with light blue dots and female with light pink triangles) and with ColXist induction 
from E11.5 over 4 weeks (A, male indicated with dark blue dots and female with dark 
pink triangles) shows no significant difference in weight. Sagittal cryosections of 
control and ColXist induced brains, shown in H&E stain, reveal no severe structural 
discrepancy (B). 
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3.5 Establishment of an in vitro system  
 
3.5.1 Derivation of homozygous inducible ESC lines 
 
To further investigate the molecular reason for the developmental failure, we 
established an in vitro system with ESCs homozygous for the inducible ColXist RNA 
transgene on both chromosomes 11. Thirty E3.5 blastocysts were isolated and cultured 
under 2i conditions to obtain ES cell lines. In addition, eight E3.5 blastocysts 
homozygous inducible for full length Xist RNA from chromosome 11 were isolated and 
taken in culture. Unfortunately, no ESC line with inducible full length Xist RNA and 
only seven out of thirty ESC lines inducible for ColXist RNA could be maintained in 
culture after few passages. Seven ESC lines homozygous inducible for ColXist RNA 
could be expanded in culture which maintained a typical ESC morphology (Fig. 14A).  
 
3.5.2 Sex determination of derived ESC lines 
 
To determine the sex of the derived ESC lines, cells were differentiated with retinoic 
acid for five days without the addition of doxycycline to the culture medium. 
Differentiated cells were grown on ROBOZ slides and Xist RNA FISH was performed 
to detect the inactive X chromosome in female cells. All of the seven cell lines showed 
an Xist RNA signal in interphase nuclei in around 40% of the cells, which refers to the 
inactive X chromosome in differentiation in vitro in female cells (Wutz and Jaenisch, 
2000). To confirm inducible homozygous transgene expression from both chromosomes 
11, ESCs were differentiated with retinoic acid and addition of doxycycline to the 
culture medium for five days. Xist RNA FISH analysis revealed three signals in around 
40% of the cells and two signals from the transgene expression in around 80% of the 
cells (Fig. 14B).  
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Figure 14  Morphology and Xist RNA FISH of seven independently derived ES 
cell lines homozygous for ColXist expression from both  
chromosomes 11 
 
Phase contrast images show typical ESC morphology of the seven derived ESC lines 
under 2i culture conditions (A). Xist RNA FISH analysis after 5 days of differentiation 
without doxycycline reveals one inactive X chromosome per interphase nucleus in 
around 40% of cells (B). After 5 days of differentiation with doxycycline 3 Xist RNA 
signals can be detected per nucleus in around 40% of cells, whereof 2 signals show 
homozygous ColXist expression from chromosome 11 and one signal indicates the 
endogenous Xist RNA expression from the Xi.  
 
 
To confirm the sex determination by Xist RNA FISH analysis, genomic DNA was 
isolated from the seven derived ESC lines and PCR was performed with primers 
specifically for amplification of a Y chromosome linked gene (Zfy) and Tsix 
amplification as an experimental control (Fig. 15B). The male positive control, with 
concentration of 200 ng/µl genomic DNA, shows the amplified Zfy product and Tsix 
amplification. The ESC samples with concentrations of 100-200 ng/µl genomic DNA 
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show no amplified Zfy product which suggests that all of the seven derived ESC lines 
are female.     
 
3.5.3 Homozygous ColXist expression in differentiation in vitro shows no 
significant cell death 
 
To investigate the effect of ColXist RNA expression from both chromosomes 11 in 
vitro, ESCs were differentiated with retinoic acid for five days with and without the 
addition of doxycycline to the culture medium, respectively. Cell counting revealed no 
significant cell death after homozygous induction of the transgenic ColXist RNA which 
is consistent with previous findings in male cells bearing the mutant Xist RNA without 
repeat A on their X chromosome (Pullirsch, et al., 2010) (Fig.15A). Slightly lower cell 
counts could be observed in five cell lines, which could be explained by little effect of 
doxycycline addition to the culture medium. TXY cells, which are male cells carrying 
an inducible Xist RNA transgene on their X chromosome, were used as a control. The 
induction of Xist RNA in these cells results in silencing of their X chromosome and is 
therefore not compatible with differentiation.  
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Figure 15  Sex determination of derived ES cell lines with PCR amplification 
and cell counting after 5 days of differentiation with retinoic acid 
 
The amplification of a Y chromosome linked gene (Zfy) by PCR is shown for sex 
determination of the seven derived ES cell lines (A). Genomic DNA of the ESCs were 
used in two different concentrations, 5 ng/µl and 100-200 ng/µl. As controls two male 
samples were used, 5 ng/µl and 200 ng/µl, respectively and one female sample. The 
amplification of Tsix was used as an experimental control. The two male control 
samples show amplification of the male specific Zfy gene (318 bp) and the 200 ng/µl 
sample shows Tsix (494 bp) amplification. The 5 ng/µl concentrated sample shows no 
Tsix amplification which can be explained by the low concentration. ESC samples with 
100-200 ng/µl show no Zfy amplification, but positive Tsix controls which suggests that 
all the seven derived ESC lines are female. Cell counting was performed with Vi-CELL 
viable cell counter. Comparison of counted cells after five days of differentiation with 
(+) or without (-) doxycycline of each derived cell line is shown (B). TXY cells, used as 
a control, show cell death after silencing the X chromosome by transgenic Xist RNA 
induction in differentiation (TXY+). The seven derived cell lines (1,2,3,5,6,12,14) show 
no significant cell death after ColXist induction. 
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3.5.4 Genome-wide gene expression profiling 
 
To investigate if genes are misregulated by the expression of the mutant Xist RNA from 
both chromosomes 11 we have performed a genome-wide gene expression profiling 
using Affymetrix 3´IVT expression analysis, GeneChip Mouse Genome 430 2.0 from 
Atlas Biolabs company. We aimed to compare differences in the expression profiles of 
three independently derived ES cell lines either differentiated with or without 
doxycycline for five days. The genome-wide expression analysis shows no major 
differences in the expression profile between the transgene induced and not induced cell 
lines (Fig. 16, A). Xist RNA is clearly overexpressed after differentiation with induced 
ColXist RNA expression and the most downregulated genes are expressed from 
chromosome 11, which include Tom1l1 (target of myb1-like 1 (chicken)), Pctp 
(phosphatidylcholine transfer protein) and Mmd (monocyte to macrophage 
differentiation-associated). In the scatter plot diagram of chromosome 11 genes it is 
shown that gene expression differences between differentiation with doxycycline and 
without doxycycline do not vary strongly and most genes are located on the diagonal 
(Fig. 16, B). The illustration of the expression profiles of all genes with fold         
change ≥ 1.0 and p-value ≤ 0.05 shows an equal distribution of up- (967) and 
downregulated (933) genes (Fig. 16, E). In contrast chromosome 11 genes show a shift 
to downregulation with ¼ up- and ¾ downregulated genes (Fig. 16, F). 
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Figure 16 Scatter plot diagrams of gene expression differences 
 
The scatter plot displays the expression difference between differentiated cells with 
doxycycline (X-axis) and without doxycycline (Y-axis) of the whole mouse genome. 
Every dot represents a gene, low expressed genes are indicated in blue and highly 
expressed genes in red. Genes which are expressed at a same level in differentiation 
with and without ColXist induction are arranged on a diagonal. The scatter plot of all 
45101 genes shows no significant misregulation in the majority of genes (A). Xist RNA 
is clearly upregulated after transgene induction with doxycycline. The three major 
downregulated genes, Tom1l1, Pctp and Mmd are indicated which are all expressed 
from chromosome 11. All chromosome 11 genes with fold change ≥ 1.0 and p-value ≤ 
0.05 are shown (B), 55 upregulated (C) and 152 downregulated (D) chromosome 11 
genes are indicated in seperate diagrams. 
Scatter plot of all genes with fold change ≥ 1.0 and p-value ≤ 0.05 shows 1900 genes 
with equal distribution of upregulated (967) and downregulated (933) genes (E). In 
comparison genes on chromosome 11 show a shift to downregulation with ¼ 
upregulated and ¾ downregulated genes (F). 
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Statistical analysis revealed 55 up- and 152 downregulated chromosome 11 genes with 
significant cut off at fold change ≥ 1.0 and p-value ≤ 0.05. The 55 upregulated genes 
show highest fold changes of 1,2 which shows only low significance. The six most 
significant downregulated genes with fold change >1,5 were compared with published 
data of predicted Polycomb target genes (Boyer, et al., 2006) which shows that five of 
these genes are not targets of PcG complexes (Table 2). No reference was found for 
Riken cDNA 6720460F02. Comparison to the ES cell differentiation level in 36 cells 
(Wutz and Jaenisch, 2000) shows that Tom1l1, Pctp and Pttg1 (pituitary tumor-
transforming gene 1) are downregulated in differentiation without doxycycline, and 
even more with differentiation with doxycycline. For Mmd, Riken cDNA 6720460F02 
and Tmem98 (transmembrane protein 98) no references could be found.  
 
 
Gene Fold change PcG target Regulation in 
differentiation –dox 
Tom1l1 -2,62 - -1,31 
Pctp -2,52 - -1,21 
Mmd -2,24 - ? 
6720460F02Rik -1,83 ? ? 
Tmem98 -1,79 - ? 
Pttg1 -1,56 - -6,20 
 
 
Table 2 Downregulated chromosome 11 genes with fold change >1,5 
 
Six downregulated genes with fold change >1,5 and p-value <0,05 are shown which are 
not Polycomb target genes. No reference for Riken cDNA 6720460F02 was found. 
Tom1l1, Pctp and Pttg1 are downregulated in differentiation without doxycycline and 
even more in differentiation with doxycycline.   
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Gene Fold change 
Myo1d -1,47 
Stxbp4 -1,47 
Prkca -1,40 
A530047J11Rik -1,40 
Nog -1,37 
Sox9 -1,36 
Cox11 -1,35 
Ccdc99 -1,32 
6330403K07Rik -1,31 
Taf15 -1,30 
Gabra1 -1,29 
Eme1 -1,29 
Wscd1 -1,29 
Cox10 -1,28 
Usp43 -1,28 
2810001G20Rik -1,28 
Samd14 -1,28 
Gsg2 -1,28 
LOC100048559 /// Sfrs1 -1,27 
Rnf145 -1,24 
Lrrc59 -1,23 
Ttc1 -1,23 
Utp18 -1,22 
Mrpl27 -1,22 
Stat5a 1,22 
Gna13 -1,21 
Sfrs2 -1,20 
 
Table 3  Up- and downregulated chromosome 11 genes with fold change >1,2 
 
Up- and downregulated genes with fold change >1,2 and p-value <0,05 are shown. Only 
one of 27 genes is upregulated in differentiation with doxycycline. 
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4 Discussion 
 
The role of Xist RNA expression in induction and maintenance of chromosome-wide 
gene silencing has been intensely studied over the last decades. The establishment of 
inducible expression systems and integration of transgenes on the X chromosome as 
well as on autosomes represent a useful tool to investigate Xist RNA function in 
development (Wutz and Jaenisch, 2000). In this study we investigated the consequences 
of expression of a mutant Xist RNA lacking repeat A from chromosome 11 on mouse 
embryonic development and tried to explain the molecular reason for the unexpected 
severe phenotype.  
 
4.1 Homozygous and heterozygous ColXist expression in early 
development leads to embryonic lethality most likely before E9.5 
 
Our investigations show that neither homozygous nor heterozygous expression of 
ColXist RNA is compatible with mouse embryonic development. This result was 
surprising due to previous observations that the mutant Xist RNA lacking repeat A has 
only little effect on the differentation potential and cell survival (Pullirsch, et al., 2010). 
However, these investigations were observed in vitro and with transgene expression 
from the X chromosome in male cells, the in vivo effect remains to be investigated. 
Experiments with different timepoints of ColXist induction and dissection suggest 
aberrant development most likely before E9.5. The dissected embryos showed a 
resorbed morphology, although the placenta seemed normally developed. This could 
indicate a failure in lineage differentiation of the embryonic tissues, although it remains 
speculative if the extraembryonic development is not affected. Expression of ColXist 
RNA might implicate a malfunction in regulation of genes in development which could 
be explained either by the disruption of gene expression patterns by epigenetic 
modifications or the sequestration of epigenetic regulators. Thereby, the ColXist RNA-
coated chromosome 11 could act as a sink for heterochromatic factors like 
heterochromatin protein-1 (HP1), limiting the availability of these factors for silencing 
of other heterochromatic loci (Chadwick and Willard, 2003) 
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Notably, the phenotype can be observed in mice heterozygous for the transgenic ColXist 
RNA as well and is independent of the parental origin of the transgene whereby, a 
maternal effect can be excluded. The targeted single copy insertion of the transgene at 
the 3´end of Col1a1 locus on chromosome 11 precludes the possibility of Col1a1 
disruption which would implicate amongst others severe defects in blood vessel 
formation, which could cause the observed phenotype. This is confirmed by a control 
experiment in which embryos carrying the maternal transmitted transgene, without 
induction by doxycycline, develop normally until E14.5. Furthermore, a toxic effect of 
doxycycline can be excluded regarding to a control experiment where embryos, lacking 
the transgene, were treated with doxycycline and normally developed E13.5 embryos 
could be observed.  
 
4.2 No obvious phenotype can be observed after heterozygous 
ColXist expression from E11.5  
 
Studies on Xist function in different cellular contexts and timepoints in development 
revealed its silencing function up to E9.5 and showed that expression after E12.5 was 
compatible with normal development until birth. However, Xist expression has an effect 
on the haematopoeitic system which leads to death shortly after birth (Savarese, et al., 
2006). These investigations show the susceptibility to silencing by Xist in stem cell 
niches like the haematopoeitic system, which remains over the lifespan of mice (Agrelo, 
et al., 2009).  
We aimed to investigate the effect of heterozygous ColXist RNA expression from E11.5 
over a time period of four weeks on mouse development and the haematopoeitic system. 
Our observations showed no postnatal lethality and no obvious phenotype in born mice. 
We conclude that the heterozygous expression of ColXist RNA from chromosome 11 
has no severe effect on the differentiation potential of precursor cells in the 
haematopoeitic lineage and is compatible with normal development at least until eight 
weeks after birth. 
Furthermore, we aimed to observe any obvious effect in late development. Therefore, 
ColXist RNA was induced from E11.5 over a period of four weeks and mice were 
examined for any obvious peculiarity in behaviour and appearance. Mice showed 
normal motoric behaviour and two out of twelve mice revealed one cloudy eye each, 
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which could indicate a possible transgene effect. However, this observation applied only 
to a small fraction of mice and has to be further investigated for significance. 
The dissected brains of ColXist RNA induced mice and control mice without the 
transgene expression showed no significant difference in weight. Furthermore, no 
severe structural discrepancy could be observed by comparison of sagittal sections.  
We conclude that ColXist RNA expression from a late timepoint in development 
(E11.5) and continued postnatal induction of the transgene has no obvious effect on 
mouse development. 
4.3 Trimethylation of histone H3 lysine 27 (H3K27m3) is established 
by ColXist RNA expression 
 
Immunofluorescence analysis show that the prominent heterochromatin mark 
H3K27m3 is established on chromosome 11 by the expression of ColXist RNA. The 
trimethylation of histone H3 lysine 27 is caused by PRC2 (Plath, et al., 2003) and 
indicates successful recruitment by the transgenic Xist RNA lacking repeat A to the 
autosome. 
We could observe established H3K27m3 after in vivo ColXist induction in early 
development as well as after induction in isolated MEFs in culture. Previous 
investigations showed that Xist loses its silencing function in differentiation and a 
cellular context is necessary (Savarese, et al., 2006) (Wutz and Jaenisch, 2000). 
However, it has been shown that in differentiated cells Xist RNA still localizes to the 
chromosome and H3K27m3 can be established independently of silencing (Kohlmaier, 
et al., 2004).  
Our results confirm these data and show establishment of H3K27m3 at an average of 
80% both after in vivo induction from E4.5 and in vitro induction in MEFs in culture. In 
female cells heterozygous for transgenic ColXist RNA the inactive X chromosome and 
chromosome 11 can be observed in condensed metaphase spreads. Furthermore, the co-
localization of Xist RNA and H3K27m3 can be observed in interphase nuclei.  
The recruitment of the histone variant macroH2A has been shown to be dependent of 
Xist expression and is involved in chromosomal memory (Pullirsch, et al., 2010). 
Previous investigations showed that recruitment of macroH2A by a mutant Xist RNA 
lacking repeat A can be observed by a low percentage of around 30% (Pullirsch, et al., 
2010). Our investigations showed weak signals of co-localization of Xist RNA and 
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macroH2A by a low percentage (data not shown) and further investigations would give 
insights of the recruitment of other known heterochromatin proteins. 
Furthermore, our results show the establishment of H3K27m3 in isolated spleen cells by 
an average of 80% of cells. We conclude that PRC2 can be recruited by the mutant 
ColXist RNA without repeat A and establishes H3K27m3 on chromosome 11. This 
applies to induction at an early timepoint in development, induction in MEFs in culture 
as well as in cells of haematopoeitic system after incuction from E11.5 independently of 
silencing.  
 
4.4 No noticeable hypoacetylation of histone H4 on chromosome 11 
can be observed 
  
Histone H4 hypoacetylation is a prominent mark of the Xi in differentiated cells 
(Keohane, et al., 1996), its maintenance is independent of Xist expression and 
contributes to stable gene silencing on the inactive X chromosome (Csankovszki, et al., 
1999). Previous investigations on the requirement of repeat A and gene silencing for 
chromosome-wide histone H4 hypoacetylation revealed a barely deacetylated X 
chromosome with bands of acetylated histone H4 which suggested regions of active 
genes (Pullirsch, et al.). These observations were in contrast with the chromosome-wide 
hypoacetylation known from the Xi (Keohane, et al., 1996).  
Immunofluorescence co-stainings of H3K27m3 and histone H4 acetylation reveal no 
noticeable H4 hypoacetylation of chromosome 11 in contrast to the chromosome-wide 
deacetylation of the inactive X chromosome. Enlarged images of the autosome suggest 
only partial deacetylation near the centromeric region. We obtained this result after in 
vivo ColXist induction in early development as well as after in vitro induction in MEFs 
in culture and in isolated spleen cells. We assume that the presence of active gene 
regions on chromosome 11 is responsible for the acetylation mark.     
 
In summary, we observe that even heterozygous ColXist expression from chromosome 
11 in vivo is not compatible with embryonic development and leads to embryonic 
lethality most likely before E9.5. In contrast, heterozygous ColXist expression from 
E11.5 has no effect on late mouse development and lineage specific differentiation of 
the haematopoeitic system seems to be unaffected. Trimethylation of histone H3 lysine 
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27 can be observed in an average of 80% of cells after both, in vivo induction in 
development, as well as after in vitro induction in differentiated cells. No noticable 
hypoacetylation of histone H4 can be observed though. 
 
4.5 Only female ES cell lines homozygous inducible for ColXist 
expression could be derived 
 
For investigating the molecular reason of the severe phenotype we established ES cell 
lines homozygous for inducible ColXist RNA from both chromosomes 11. Seven cell 
lines out of thirty isolated E3.5 blastocysts could be established and surprisingly, all 
seven cell lines were female. The remaining ColXist ES cells could not be maintained in 
culture under 2i conditions. Furthermore, the establishment of an ES cell line with 
inducible full lenght Xist transcript from chromosome 11 could not be obtained either. 
It can be speculated that the isolation of seven female ES cell lines happened by chance 
and any significance has to be recapitulated by repeating this experiment. However, this 
would be an unlikely coincidence. Furthermore, it has to be noted that no transgene 
expression was induced before blastocyst isolation. Therefore, any gene silencing 
function or sequestration of heterochromatin proteins can be excluded for explaining 
this result. Another possible explanation could be an involved counting mechanism, 
which achieves survival of female cells only. At the moment this remains speculative as 
the cells only carry the mutated Xist RNA and no other regulatory elements of the        
X inactivation centre are present, which is believed to be involved in the counting 
mechanism (Monkhorst, et al., 2008). Future investigation of a potential role of the 
ColXist transgene in regulation of X inactivation during ES cell derivation could clarify 
this observation. 
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4.6 In vitro differentiation shows no significant cell death 
 
For investigating the effect of homozygous ColXist RNA expression from both 
chromosomes 11 in differentiation in vitro, we used the established ES cell lines and 
differentiated them for five days with retinoic acid with and without doxycycline, 
respectively. Our results show no significant cell death after homozygous induction of 
the transgenic Xist RNA. This is consistent with observations from previous 
investigations where only three genes on chromosome 11 were significantly 
downregulated by Xist in homozygous ES cells at day 4 of differentiation which shows 
only little effect of Xist lacking repeat A on gene expression (Pullirsch, et al., 2010). 
From the obtained results we claim that ColXist RNA expression from chromosome 11 
might prevent upregulation of genes involved in lineage formation at an early timepoint 
in development. We suggest that an early lineage decision is affected, which results in a 
developmental failure but shows only little effect on differentiation in vitro. 
 
4.7 Genome-wide gene expression profiling 
Our results of genome-wide gene expression profiling shows only slightly changes in 
gene expression patterns. This result supports our expectation of no significant gene 
silencing function of the mutant Xist RNA without repeat A. The statistical analysis of 
the experiment with three independently derived cell lines shows highly upregulated 
Xist RNA expression, which approves the experimental approach, and slightly 
downregulated genes, which are mainly chromosome 11 genes. These include Tom1l1 
(target of myb1-like 1 (chicken)), Pctp (phosphatidylcholine transfer protein) and Mmd 
(monocyte to macrophage differentiation-associated). If the low downregulation of one 
of these genes or interaction of several misregulated genes on chromosome 11 is 
responsible for the observed phenotype remains to be investigated. 
Our investigations suggest that slightly misregulation of gene expression patterns has 
severe consequences on mouse embryonic development. These minor changes might 
not be investigated after in vitro differentiation with retinoic acid. Another approach 
might be the diffferentiation into embryonic bodies to exclude lineage specific 
differentiation promoted by retinoic acid. Furthermore, quantitative expression analysis 
with reverse transcriptase real time PCR would provide further information about up- or 
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downregulation of specific genes in differentiation compared to the ES cell expression 
profile.  
In summary the genome-wide gene expression profiling reveals a shift to 
downregulation of chromosome 11 genes. Other chromosomes do not seem to be 
affected by transgenic Xist RNA expression due to equal distribution of up- and 
downregulated genes. It is clearly shown that ¾ of chromosome 11 genes are 
downregulated in differentiation with ColXist RNA expression. However, fold changes 
do not excess 2,6 which is relatively low. Furthermore, our investigations show that 
downregulated genes are no Polycomb target genes (Boyer, et al., 2006) and seem to be 
downregulated upon differentiation. This is contrary to our assumption that affected 
genes are prevented from upregulation in differentiation by ColXist RNA expression. 
Overall, our data suggest that the transgenic Xist RNA lacking repeat A remains some 
silencing function on chromosome 11. 
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5 Summary 
 
The non-coding Xist RNA is the trigger of chromosome-wide gene repression during  
X inactivation in mammals. Gene repression depends on a repeated sequence on the 5´ 
of Xist. Studies in mouse embryonic stem cells (ESCs) have shown that this repeat A 
element is essential for the initiation of gene silencing by Xist. Expression of Xist 
lacking repeat A has been shown to lead to an X chromosome which possesses all 
chromatin modifications of the inactive X chromosome (Xi) but genes remain active.  
Here, we investigate if such a chromosome configuration can be compatible with 
development. For this we have established mice harbouring transgene for inducible 
expression of repeat A deleted Xist RNA from the Col1a1 locus on chromosome 11. We 
show that induction of Xist lacking repeat A in embryonic cells leads to histone H3 
lysine 27 tri-methylation (H3K27m3) but no noticeable decrease in histone H4 
acetylation. Our experiments reveal an unexpected strong phenotype leading to 
embryonic lethality most likely before embryonic day 9.5. Notably, the phenotype was 
observed also in mice heterozygous for the transgenic chromosome 11 and independent 
of the parental origin of the transgene. However, no obvious phenotype could be 
observed after late induction of Xist. This suggests that in early development gene 
expression patterns might be disrupted by epigenetic modifications triggered by Xist 
without repeat A. 
To investigate the molecular basis of this phenotype we have established ESCs from 
homozygous transgene bearing blastocysts and performed genome-wide gene 
expression profiling using Affymetrix mouse array analysis of three independently 
derived ES cell lines either with induction of Xist or without. We compared expression 
differences between induced and non-induced cells after 5 days of differentiation with 
retinoic acid. Our results show only little misregulation of genes with low fold changes. 
However, we could investigate a higher percentage of downregulated genes on 
chromosome 11 which suggests remaining silencing function of transgenic Xist RNA 
lacking repeat A in an autosomal context. Most significantly downregulated genes are 
no Polycomb target genes and seem to be downregulated upon differentiation. The 
assumption that developmental genes are prevented to be upregulated upon 
differentiation by transgenic Xist RNA expression could not be confirmed. 
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Overall, our results show that expression of Xist RNA lacking repeat A from 
chromosome 11 establishes H3K27m3, but no significant H4 hypoacetylation. Genes on 
this modified chromosome are slightly downregulated which is obviously not 
compatible with mouse embryonic development. We suggest that misregulated genes on 
chromosome 11 are necessary for a lineage specific differentiation pathway early in 
development and already little downregulation causes embryonic lethality. 
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6 Zusammenfassung 
 
Die nicht-kodierende Xist RNA ist entscheidend für die Initiation der chromosomweiten 
Genrepression während der X-Inaktivierung in weiblichen Säugetierzellen. Die 
Stilllegung X-spezifischer Gene ist abhängig von einer sich wiederholenden Sequenz 
am 5´Ende von Xist. Untersuchungen an murinen embryonalen Stammzellen zeigten, 
dass dieses sogenannte „repeat A“-Element essenziell für die Initiation der 
Genrepression durch Xist ist. Es wurde gezeigt, dass die Expression einer Xist RNA mit 
fehlendem repeat A zwar alle charakteristischen Chromatinmodifikationen herbeiführen 
kann, Gene an diesem Chromosom jedoch aktiv bleiben. 
In diesem Projekt wird untersucht, ob eine solche Chromosomen-Konfiguration mit der 
embryonalen Entwicklung vereinbar ist. Dafür wurde ein transgenes Mausmodell 
etabliert, bei dem die Expression einer Xist RNA mit fehlendem repeat A am 3´Ende 
des Col1a1 Locus am Chromosom 11 mittels Doxyzyklin induzierbar ist. Es wird 
gezeigt, dass die Expression der mutierten Xist RNA zu Histon H3 - Lysin 27-
trimethylierung (H3K27m3) führt, jedoch keine erkennbare Histon H4 - Deacetylierung 
beobachtet werden kann.  
Die Expression der transgenen Xist RNA ohne repeat A in vivo in der frühen 
embryonalen Entwicklung zeigt einen starken, unerwarteten Phänotyp, der zu 
embryonaler Letalität vor Tag 9.5 der Embryonalentwicklung führt (E9.5). 
Interessanterweise wurde dieser Phänotyp ebenso bei heterozygoter Expression des 
Transgens beobachtet und ist unabhängig von der parentalen Herkunft der Xist RNA. 
Expression in einem späteren Stadium der Entwicklung (E11.5) zeigt keinen 
offensichtlichen Phänotyp was darauf hinweisen könnte, dass Genexpressionsmuster in 
der frühen embryonalen Entwicklung durch epigenetische Modifikationen gestört 
werden.  
Um den molekularen Mechanismus des beobachteten Phänotyps zu untersuchen, 
wurden embryonale Stammzelllinien aus Blastocysten etabliert, welche homozygot 
induzierbare Xist RNA ohne repeat A am Chromosom 11 tragen. Mit Hilfe dieses         
in vitro Systems wurde eine genomweite Genexpressionsanalyse mittels Affymetrix 
Maus Array durchgeführt. Drei unabhängig voneinander isolierte embryonale 
Stammzelllinien wurden mit Retinolsäure für 5 Tage entweder mit oder ohne 
Doxyzyklin differenziert und die Unterschiede in der Genexpression zwischen 
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induzierten und nicht induzierten Zelllinien verglichen. Die Ergebnisse zeigen nur 
minimale Unterschiede in der Genexpression. Ein höherer Prozentsatz an 
herunterregulierten Genen konnte am Chromosom 11 beobachtet werden was darauf 
hinweist, dass Expression der transgenen Xist RNA ohne repeat A eine verbleibende 
Funktion in der Gen-Stilllegung im autosomalen Kontext aufweist. Die am stärksten 
herunterregulierten Gene sind keine Zielgene für Polycomb-Komplexe und scheinen in 
der Differenzierung herunterreguliert zu werden.  
Zusammenfassend zeigen die Ergebnisse, dass die Expression einer transgenen Xist 
RNA ohne repeat A vom Chromosom 11 zwar H3K27m3 etabliert, jedoch keine 
signifikante H4 Deacetylierung beobachtet werden kann. Dreiviertel der Gene, die am 
Chromosom 11 lokalisiert sind, werden in geringem Ausmaß herunterreguliert, was 
offensichtlich mit der embryonalen Entwicklung der Maus nicht vereinbar ist. Es ist 
anzunehmen, dass die betroffenen Gene notwendig sind für spezifische 
Differenzierungswege in der frühen embryonalen Entwicklung und bereits geringe 
Änderungen in der Expression zu embryonaler Letalität führen.   
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